BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9892644)

  • 1. Myosin I heavy chain kinase: cloning of the full-length gene and acidic lipid-dependent activation by Rac and Cdc42.
    Brzeska H; Young R; Knaus U; Korn ED
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):394-9. PubMed ID: 9892644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin-binding and autoinhibitory domains of Acanthamoeba myosin I heavy chain kinase, a p21-activated kinase (PAK).
    Brzeska H; Young R; Tan C; Szczepanowska J; Korn ED
    J Biol Chem; 2001 Dec; 276(50):47468-73. PubMed ID: 11579107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of a Dictyostelium myosin I heavy chain kinase activated by Cdc42 and Rac.
    Lee SF; Egelhoff TT; Mahasneh A; Côté GP
    J Biol Chem; 1996 Oct; 271(43):27044-8. PubMed ID: 8900194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21-activated kinase has substrate specificity similar to Acanthamoeba myosin I heavy chain kinase and activates Acanthamoeba myosin I.
    Brzeska H; Knaus UG; Wang ZY; Bokoch GM; Korn ED
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1092-5. PubMed ID: 9037011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the p21-activated kinase-related Dictyostelium myosin I heavy chain kinase by autophosphorylation, acidic phospholipids, and Ca2+-calmodulin.
    Lee SF; Mahasneh A; de la Roche M; Côté GP
    J Biol Chem; 1998 Oct; 273(43):27911-7. PubMed ID: 9774403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catalytic domain of acanthamoeba myosin I heavy chain kinase. II. Expression of active catalytic domain and sequence homology to p21-activated kinase (PAK).
    Brzeska H; Szczepanowska J; Hoey J; Korn ED
    J Biol Chem; 1996 Oct; 271(43):27056-62. PubMed ID: 8900196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the Rac/PAK pathway in Amoeba proteus.
    Kłopocka W; Moraczewska J; Redowicz MJ
    Protoplasma; 2005 Apr; 225(1-2):77-84. PubMed ID: 15948264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mutating the regulatory phosphoserine and conserved threonine on the activity of the expressed catalytic domain of Acanthamoeba myosin I heavy chain kinase.
    Szczepanowska J; Ramachandran U; Herring CJ; Gruschus JM; Qin J; Korn ED; Brzeska H
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4146-51. PubMed ID: 9539704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophosphorylation-independent activation of Acanthamoeba myosin I heavy chain kinase by plasma membranes.
    Kulesza-Lipka D; Brzeska H; Baines IC; Korn ED
    J Biol Chem; 1993 Aug; 268(24):17995-8001. PubMed ID: 8394357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The catalytic domain of Acanthamoeba myosin I heavy chain kinase. I. Identification and characterization following tryptic cleavage of the native enzyme.
    Brzeska H; Martin BM; Korn ED
    J Biol Chem; 1996 Oct; 271(43):27049-55. PubMed ID: 8900195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family.
    Manser E; Chong C; Zhao ZS; Leung T; Michael G; Hall C; Lim L
    J Biol Chem; 1995 Oct; 270(42):25070-8. PubMed ID: 7559638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (gamma-PAK).
    Chew TL; Masaracchia RA; Goeckeler ZM; Wysolmerski RB
    J Muscle Res Cell Motil; 1998 Nov; 19(8):839-54. PubMed ID: 10047984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity of Acanthamoeba myosin I heavy chain kinase as determined with synthetic peptides.
    Brzeska H; Lynch TJ; Martin B; Corigliano-Murphy A; Korn ED
    J Biol Chem; 1990 Sep; 265(27):16138-44. PubMed ID: 2168881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Acanthamoeba myosin I heavy chain kinase by Ca(2+)-calmodulin.
    Brzeska H; Kulesza-Lipka D; Korn ED
    J Biol Chem; 1992 Nov; 267(33):23870-5. PubMed ID: 1331103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational switch and role of phosphorylation in PAK activation.
    Buchwald G; Hostinova E; Rudolph MG; Kraemer A; Sickmann A; Meyer HE; Scheffzek K; Wittinghofer A
    Mol Cell Biol; 2001 Aug; 21(15):5179-89. PubMed ID: 11438672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AR and ER interaction with a p21-activated kinase (PAK6).
    Lee SR; Ramos SM; Ko A; Masiello D; Swanson KD; Lu ML; Balk SP
    Mol Endocrinol; 2002 Jan; 16(1):85-99. PubMed ID: 11773441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of the Cdc42/Rac-binding domain of p21-activated kinase.
    Thompson G; Owen D; Chalk PA; Lowe PN
    Biochemistry; 1998 May; 37(21):7885-91. PubMed ID: 9601050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dictyostelium PAKc is required for proper chemotaxis.
    Lee S; Rivero F; Park KC; Huang E; Funamoto S; Firtel RA
    Mol Biol Cell; 2004 Dec; 15(12):5456-69. PubMed ID: 15483055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of Acanthamoeba myosin I heavy chain kinase bound to phospholipid vesicles.
    Wang ZY; Brzeska H; Baines IC; Korn ED
    J Biol Chem; 1995 Nov; 270(46):27969-76. PubMed ID: 7499274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of myosin in HeLa cells causes redistribution of focal adhesions and F-actin from cell center to cell periphery.
    Szczepanowska J; Korn ED; Brzeska H
    Cell Motil Cytoskeleton; 2006 Jun; 63(6):356-74. PubMed ID: 16607629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.